The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Twist Bioscience Corp shares valued at $97,429 were sold by Finn Patrick John on Oct 23 ’24. At $43.09 per share, Finn Patrick John sold 2,261 shares. The insider’s holdings dropped to 159,483 shares worth approximately $6.44 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Finn Patrick John purchased 2,261 shares, netting a total of over 97,429 in proceeds.
Before that, Laponis Adam had sold 856 shares from its account. In a trade valued at $35,791, the Chief Financial Officer traded Twist Bioscience Corp shares for $41.81 each. Upon closing the transaction, the insider’s holdings decreased to 856 shares, worth approximately $2.96 million.
As published in their initiating research note from Guggenheim on June 04, 2024, Twist Bioscience Corp [TWST] has been a Buy and the price target has been revised to $53. Analysts at Goldman upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in mid January. As of September 27, 2023, Berenberg has initiated its “Buy” rating for TWST. Earlier on January 05, 2023, Scotiabank initiated its rating. Their recommendation was “a Sector outperform” for TWST stock.
Analyzing TWST Stock Performance
During the last five days, there has been a surge of approximately 0.30%. Over the course of the year, Twist Bioscience Corp shares have jumped approximately 9.50%. Shares of the company reached a 52-week high of $60.90 on 07/26/24 and a 52-week low of $27.41 on 04/19/24. A 50-day SMA is recorded $43.71, while a 200-day SMA reached $42.13. Nevertheless, trading volume fell to 0.59 million shares from 0.39 million shares the previous day.
Support And Resistance Levels for Twist Bioscience Corp (TWST)
According to the 24-hour chart, there is a support level at 39.56, which, if violated, would cause prices to drop to 38.75. In the upper region, resistance lies at 41.93. The next price resistance is at 43.49. RSI (Relative Strength Index) is 40.67 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.53, which suggests the price will decrease in the coming days. Percent R is at 97.95%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
